Publications-ELK Biotechnology CO.,Ltd.

Technical

IF：5.714 Date：2022-10-21

International Immunopharmacology

Maresin1 ameliorates ventricular remodelling and arrhythmia in mice models of myocardial infarction via NRF2/HO-1 and TLR4/NF-kB signalling

Products：
IF：5.7 Date：2024-04-22

Molecular Cancer Therapeutics

SMG5 Inhibition Restrains Hepatocellular Carcinoma Growth and Enhances Sorafenib Sensitivity

Products： ELK8108
IF：5.7 Date：2024-08-08

Frontiers in Immunology

Unveiling the bioinformatic genes and their involved regulatory mechanisms in type 2 diabetes combined with osteoarthritis

Products： EP013
IF：5.7 Date：2024-01-22

Molecular Medicine

Comprehensive analysis of m6A modification in lipopolysaccharide-induced acute lung injury in mice

Products： ES7642

< Page of 389 >